PTCT icon

PTC Therapeutics

261 hedge funds and large institutions have $4.03B invested in PTC Therapeutics in 2025 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 86 increasing their positions, 93 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

10% more funds holding

Funds holding: 238261 (+23)

0.88% less ownership

Funds ownership: 100.76%99.88% (-0.88%)

8% less repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 93

Holders
261
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$15.8M
Puts
$12.5M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DPW
251
DiNuzzo Private Wealth
Pennsylvania
$612
RAM
252
Riggs Asset Management
Pennsylvania
$561
FFA
253
Farther Finance Advisors
California
$559
GFPC
254
Global Financial Private Client
Florida
$510
IA
255
IFP Advisors
Florida
$408
SS
256
SBI Securities
Japan
$408
BIG
257
Brooklyn Investment Group
New York
$204
PWM
258
Parkworth Wealth Management
California
$102
HIA
259
HFM Investment Advisors
New Jersey
$102
BHWM
260
Bay Harbor Wealth Management
Maryland
$50
Blackstone Inc
261
Blackstone Inc
New York
WP
262
Woodline Partners
California
CSS
263
Cubist Systematic Strategies
Connecticut
JF
264
Jump Financial
Illinois
SGDR
265
SPX Gestao de Recursos
Brazil
BBA
266
Baker Bros. Advisors
New York
Thrivent Financial for Lutherans
267
Thrivent Financial for Lutherans
Minnesota
HF
268
HRT Financial
New York
BHCM
269
Brevan Howard Capital Management
Jersey
ADIM
270
Alpha DNA Investment Management
Maryland
NRD
271
Nebula Research & Development
New York
CCIA
272
Campbell & Co Investment Adviser
Maryland
AIM
273
Aigen Investment Management
New York
VEA
274
Virtus ETF Advisers
New York
HT
275
Headlands Technologies
Illinois